Tjoapack secures investment to increase pharma packaging capabilities

The CPO has immediate plans to expand its automated packaging capabilities, including for injectable products.

Tjoapack has immediate plans to invest in expanding its automated packaging capabilities, including for injectable products, allowing the company to cater to market demand for pre-filled syringes and vial packaging.

Last year, the CPO decided to seek investment from a strong financial partner with experience in the industry to help it to achieve its long-term strategic goals. They found that partner in Ampersand Capital Partners, a private equity firm that specialises in partnering with entrepreneur-led healthcare companies.

In conjunction with the deal, Dexter Tjoa, Tjoapack’s Director of Corporate Strategy has been appointed as CEO. Eric Tjoa, the company’s founder and previous CEO, will retain a seat on the Board of Directors.

Dexter Tjoa said: “We are committed to shaping the future of the pharmaceutical supply chain and meeting the ever-changing demands of the industry. With that comes ensuring we have the capacity and capabilities to provide a comprehensive set of services to our global customer base.”